Literature DB >> 9539293

Autoregulation of hepatic glucose production.

M C Moore1, C C Connolly, A D Cherrington.   

Abstract

In vitro evidence indicates that the liver responds directly to changes in circulating glucose concentrations with reciprocal changes in glucose production and that this autoregulation plays a role in maintenance of normoglycemia. Under in vivo conditions it is difficult to separate the effects of glucose on neural regulation mediated by the central nervous system from its direct effect on the liver. Nevertheless, it is clear that nonhormonal mechanisms can cause significant changes in net hepatic glucose balance. In response to hyperglycemia, net hepatic glucose output can be decreased by as much as 60-90% by nonhormonal mechanisms. Under conditions in which hepatic glycogen stores are high (i.e. the overnight-fasted state), a decrease in the glycogenolytic rate and an increase in the rate of glucose cycling within the liver appear to be the explanation for the decrease in hepatic glucose output seen in response to hyperglycemia. During more prolonged fasting, when glycogen levels are reduced, a decrease in gluconeogenesis may occur as a part of the nonhormonal response to hyperglycemia. A substantial role for hepatic autoregulation in the response to insulin-induced hypoglycemia is most clearly evident in severe hypoglycemia (< or = 2.8 mmol/l). The nonhormonal response to hypoglycemia apparently involves enhancement of both gluconeogenesis and glycogenolysis and is capable of supplying enough glucose to meet at least half of the requirement of the brain. The nonhormonal response can include neural signaling, as well as autoregulation. However, even in the absence of the ability to secrete counterregulatory hormones (glucocorticoids, catecholamines, and glucagon), dogs with denervated livers (to interrupt neural pathways between the liver and brain) were able to respond to hypoglycemia with increases in net hepatic glucose output. Thus, even though the endocrine system provides the primary response to changes in glycemia, autoregulation plays an important adjunctive role.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9539293     DOI: 10.1530/eje.0.1380240

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  17 in total

Review 1.  Blood glucose management during critical illness.

Authors:  Barry A Mizock
Journal:  Rev Endocr Metab Disord       Date:  2003-05       Impact factor: 6.514

Review 2.  Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony.

Authors:  Mark A Herman; Barbara B Kahn
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

3.  Metabolic environment in substantia nigra reticulata is critical for the expression and control of hypoglycemia-induced seizures.

Authors:  Libor Velísek; Jana Velísková; Ondrej Chudomel; Ka-Lai Poon; Kimberly Robeson; Barbara Marshall; Archana Sharma; Solomon L Moshé
Journal:  J Neurosci       Date:  2008-09-17       Impact factor: 6.167

4.  Effects of insulin and cytosolic redox state on glucose production pathways in the isolated perfused mouse liver measured by integrated 2H and 13C NMR.

Authors:  Natasha Hausler; Jeffrey Browning; Matthew Merritt; Charles Storey; Angela Milde; F Mark H Jeffrey; A Dean Sherry; Craig R Malloy; Shawn C Burgess
Journal:  Biochem J       Date:  2006-03-01       Impact factor: 3.857

5.  Genistein ameliorates hyperglycemia in a mouse model of nongenetic type 2 diabetes.

Authors:  Zhuo Fu; Elizabeth R Gilbert; Liliane Pfeiffer; Yanling Zhang; Yu Fu; Dongmin Liu
Journal:  Appl Physiol Nutr Metab       Date:  2012-04-17       Impact factor: 2.665

6.  Insulin's direct hepatic effect explains the inhibition of glucose production caused by insulin secretion.

Authors:  Dale S Edgerton; Guillaume Kraft; Marta Smith; Ben Farmer; Phillip E Williams; Katie C Coate; Richard L Printz; Richard M O'Brien; Alan D Cherrington
Journal:  JCI Insight       Date:  2017-03-23

7.  Glucocorticoid-deficient corticotropin-releasing hormone knockout mice maintain glucose requirements but not autonomic responses during repeated hypoglycemia.

Authors:  Lauren Jacobson; Tasneem Ansari; Jessica Potts; Owen P McGuinness
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-01-31       Impact factor: 4.310

8.  MB06322 (CS-917): A potent and selective inhibitor of fructose 1,6-bisphosphatase for controlling gluconeogenesis in type 2 diabetes.

Authors:  Mark D Erion; Paul D van Poelje; Qun Dang; Srinivas Rao Kasibhatla; Scott C Potter; M Rami Reddy; K Raja Reddy; Tao Jiang; William N Lipscomb
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-23       Impact factor: 11.205

9.  Glucose autoregulation is the dominant component of the hormone-independent counterregulatory response to hypoglycemia in the conscious dog.

Authors:  Justin M Gregory; Noelia Rivera; Guillaume Kraft; Jason J Winnick; Ben Farmer; Eric J Allen; E Patrick Donahue; Marta S Smith; Dale S Edgerton; Phillip E Williams; Alan D Cherrington
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-05-16       Impact factor: 4.310

10.  Hypothalamic apelin/reactive oxygen species signaling controls hepatic glucose metabolism in the onset of diabetes.

Authors:  Anne Drougard; Thibaut Duparc; Xavier Brenachot; Lionel Carneiro; Alexandra Gouazé; Audren Fournel; Lucie Geurts; Thomas Cadoudal; Anne-Catherine Prats; Luc Pénicaud; Didier Vieau; Jean Lesage; Corinne Leloup; Alexandre Benani; Patrice D Cani; Philippe Valet; Claude Knauf
Journal:  Antioxid Redox Signal       Date:  2013-09-18       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.